Firebrick Pharma Limited (ASX:FRE)
Australia flag Australia · Delayed Price · Currency is AUD
0.0680
0.00 (0.00%)
Apr 30, 2025, 1:02 PM AEST

Firebrick Pharma Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019
Market Capitalization
15112745--
Upgrade
Market Cap Growth
46.33%-59.96%-38.95%---
Upgrade
Enterprise Value
14102241--
Upgrade
Last Close Price
0.070.060.150.27--
Upgrade
PS Ratio
13.503.981211.4541.30--
Upgrade
PB Ratio
10.205.1711.035.40--
Upgrade
P/TBV Ratio
10.205.1711.035.40--
Upgrade
EV/Sales Ratio
12.693.50993.5237.40--
Upgrade
Debt / Equity Ratio
-----0.14
Upgrade
Asset Turnover
0.601.020.000.210.350.56
Upgrade
Quick Ratio
3.316.104.9218.277.753.11
Upgrade
Current Ratio
4.437.195.1118.507.773.12
Upgrade
Return on Equity (ROE)
-111.71%-51.22%-126.49%-77.28%-251.89%-203.95%
Upgrade
Return on Assets (ROA)
-52.89%-25.33%-72.06%-41.82%-126.25%-102.32%
Upgrade
Return on Capital (ROIC)
-64.79%-29.73%-78.47%-44.65%-153.17%-118.72%
Upgrade
Earnings Yield
-11.29%-10.75%-24.90%-8.48%--
Upgrade
FCF Yield
-13.06%-21.44%-21.18%-9.46%--
Upgrade
Buyback Yield / Dilution
-10.34%-5.25%-45.98%-5.45%-265.19%-14.12%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.